• RHAMM;
  • CD44;
  • Colon cancer;
  • Real-time RT-PCR;
  • Hyaluronan


  1. Top of page
  2. Abstract

Receptor for hyaluronan (HA)-mediated motility (RHAMM) is a receptor for HA-mediated motility and its expression is correlated with malignancy of ras-transformed cells in that binding of HA to this receptor activates their migratory ability. CD44, a cell surface receptor for HA is also implicated in metastatic behavior of some cancer cells. In this study we examined the relationships of cancer progression with mRNA levels of RHAMM, CD44 (all forms), and exon 6 of CD44 using the real-time reverse transcriptase-polymerase chain reaction method in specimens of colon cancers at different diagnostic stages from 30 patients. Increased mRNA levels of RHAMM were observed in 29 specimens (97%), CD44s (all forms) in 21 specimens (70%), and its exon 6 in 19 specimens (63%) in comparison with those in the corresponding noncancerous tissue specimens. A statistically significant correlation between RHAMM expression and cancerous specimens at any of Dukes' stages A, B, and C was found, and the overexpression of CD44 mRNAs was confirmed in specimens at Dukes' stage C. Thus, our present study for the first time suggests that RHAMM expression may be a clinically useful indicator of colon cancer.


hyaluronan synthase




polymerase chain reaction


reverse transcriptase-polymerase chain reaction


receptor for hyaluronan-mediated motility


extracellular signal-regulated protein kinase

MAP kinase

mitogen-activated protein kinase


glyceraldehyde-3-phosphate dehydrogenase


  1. Top of page
  2. Abstract
  • 1)
    Toole, B. P. Cell Biology of the Extracellular Matrix, ” ed. E. D.Hey, pp. 259294 (1980). Plenum Publishing Corp., New York .
  • 2)
    Weigel, P. H., Hascall, V. C. H. and Tammi, M. Hyaluronan synthases. J. Biol. Chem., 272, 1399714000 (1997).
  • 3)
    Kimata, K., Honma, Y., Okayama, M., Oguri, K., Hozumi, M. and Suzuki, S. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res., 43, 13471354 (1983).
  • 4)
    Lesley, J., Hyman, R. and Kincade, P. W. CD44 and its interaction with the cellular matrix. Adv. Immunol., 54, 271335 (1993).
  • 5)
    Sherman, L., Sleeman, J., Herrlich, P. and Ponta, H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol., 6, 726733 (1994).
  • 6)
    Guo, Y., Ma, J., Wang, J., Che, X., Narula, J., Bigby, M., Wu, M. and Sy, M.-S. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res., 54, 15611565 (1994).
  • 7)
    Matsumura, Y. and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 10531058 (1992).
  • 8)
    Goodison, S., Yoshida, K., Sugino, T., Woodman, A., Gorham, H., Bolodeoku, J., Kaufmann, M. and Tarin, D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res., 57, 31403144 (1997).
  • 9)
    Reeder, J. A., Gotley, D. C., Walsh, M. D., Fawcett, J. and Antalis, T. M. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res., 58, 37193726 (1998).
  • 10)
    Matsumura, Y., Hanbury, D., Smith, J. and Tarin, J. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br. Med. J., 308, 619624 (1994).
  • 11)
    Turley, E. A., Austen, L., Vandeligt, K. and Clary, C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol., 112, 10411047 (1991).
  • 12)
    Hall, C. L., Yang, B., Yang, X., Zahng, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., Greenberg, A. H. and Turley, E. A. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82, 1928 (1995).
  • 13)
    Wang, C., Thor, A. D., Moore, D. H., II, Zhao, Y., Kerschmann, R., Stern, R., Watson, P. H. and Turley, E. A. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with over expression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res., 4, 567576 (1998).
  • 14)
    Turley, E. A. and Tretiak, M. Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Res., 45, 50985105 (1985).
  • 15)
    Zhang, L., Underhill, C. B. and Chen, L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55, 428433 (1995).
  • 16)
    Itano, N., Sawai, T., Miyaishi, O. and Kimata, K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res., 59, 24992504 (1999).
  • 17)
    Heid, C.A., Stevens, J. and Williams, P. M. Real time quantitative PCR. Genome Res., 6, 986994 (1996).
  • 18)
    Gibson, U. E. M., Heid, C. A. and Williams, A. Novel method for real time quantitative RT-PCR. Genome Res., 6, 9951001 (1996).
  • 19)
    Abetamann, V., Kern, H. F. and Elsasser, H. P. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells. Clin. Cancer Res., 2, 16071618 (1996).
  • 20)
    Teder, P., Bergh, J. and Heldin, P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Cancer Res., 55, 39083914 (1995).
  • 21)
    Hofmann, M., Rudy, W., Zoller, M., Tolg, C., Ponta, H., Herrlich, P. and Gunthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 52925297 (1991).